Potential Risk of Cancer from Zantac Known By Drug Maker For Decades: Report
Court records indicate GlaxoSmithKline knew Zantac's active ingredient could chemically change into a cancer-causing agent as early as 1982, and that the potential risk was there before the drug was even developed